5th Annual European HealthTech CEO Forum 2024 | Sachs Associates Ltd | 26 February 2024 | Hilton Zurich Airport Hotel, Hohenbühlstrasse 10, 8152 Opfikon, Switzerland

The physical programme will consist of the usual panels and keynotes, which will be available on demand from this year. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.

This event is a unique annual gathering of industry leaders from Europe, Asia and the USA. The main programme will feature more than 5 hours of high-level speeches and panel discussions focusing on investment & partnership in MedTech and Digital Health. In addition, there will be a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and are seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presenting tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We expect around 250+ delegates from 20+ countries to join us in Zurich for the networking and business opportunities. These include Digital Health, MedTech/Device companies, banks, investors and advisors with part of the audience participating virtually.

For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect 1800+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone and the programme will consist of:

• BioPharma Reboot: Harnessing the Power of AI & Supercomputers Panel
• New Frontiers in Personalised Medicine with AI Powered Diagnostics Panel
• Digital Solutions for Chronic & Other Medical Conditions Panel
• State of the Industry: MedTech & Device Panel
• Advances in Cardiovascular Tech Panel
• Meeting the Challenges of Medtech & Device Growth Companies Panel
• Investors Roundtable
• Rising Stars – HealthTech Seed Companies Session

2024 Speakers

KEYNOTE SPEAKER:

Jeffrey Jump
Chairman & CEO, MedAlliance SA

CHAIRS AND SPEAKERS:

André Hofmann
CEO, Biosaxony Management GmbH

Andreas Holm Mattsson
Founder & Chief AI & Culture Officer, Evaxion Biotech A/S

Arnd Kaltofen
Managing Partner, VI Partners AG

Barbara Castellano
Partner, Panakès Partners SGR SpA

Beat Lechmann
Early Innovation Partner MedTech EMEA, Johnson & Johnson Innovation LLC

Beat Merz
Managing Director, New Harbor Venture Partners, LLC

Boris Bogdan
Lead HCLS EMEA, Amazon Web Services

Carolin Barth
Partner & Director, Boston Consulting Group

Cornelia Jahnel
Head Investor Relations, biosaxony Management GmbH

Damien Ng
Thematic Research Analyst, Bank Julius Baer & Co. Ltd.

Eran Toledo
CTO, Sanara Ventures

Eric de La Fortelle
Managing Partner, Cathay Health

Finbar Dolan
CEO, Versono Medical Ltd.

Frank Bulens
Partner, imec.xpand

Frank Hensel
Principal, High-Tech Gründerfonds

Giancarlo Rizzoli
CEO, 4D Lifetec AG

Jean-François Rivassou
Partner, Kurma Partners

Jeffrey Jump
Chairman & CEO, MedAlliance SA

Jonas Brambeck
Senior Investment Director, Industrifonden

Jordi Martorell
Co-Founder & CEO, Aortyx SL

Laurent Choppe
Managing Partner, Cukierman & Co. Life Sciences

Lior Teitelbaum
Principal, Venture Investments, Johnson & Johnson Innovation – JJDC, Inc.

Magdalena Plotczyk
Investment Associate, MTIP AG

Marek Kozlowski
Senior Investment Director, NRW.Venture

Marianne Mertens
Partner, Apollo Health Ventures

Martin Mueller
Senior Investment Manager, CARMA FUND Management GmbH

Mateusz Sagan, SVP
Chief Operating Officer, SDS Optic Inc.

Michalis Papadakis
Co-Founder & CEO, Brainomix Limited

Michele Marzola
CEO, Digital Networks PLC

Mike Karim
CEO, Oxford Endovascular Ltd.Miro Venturi, Healthcare Executive/ Board Member of ArchiMed & President, DIAMANTE Healthcare Consulting

Moritz Schöllauf
Co-Founder & CEO, nyra health GmbH

Nissim Darvish
Managing Partner, ENV Ventures

Oliver Harrison, Founder
Managing Director & CEO, Koa Health Limited

Philippe Menu
EVP, Chief Product Officer & Chief Medical Officer, SOPHiA GENETICS

Rainer Metzger
Head of Integrated Clinical Services, Medicover AB

Rana Lonnen
Managing Director, dRx Capital, Novartis

Regina Hodits
Managing Partner, Wellington Partners

Sebastian Alexander
CEO, VivoSensMedical GmbH

Steve Kappenthuler
Co-Founder & CBO, MUVON Therapeutics AG

Tanja Dowe
Managing Director, Angelini Ventures S.p.A.

Todor Jeliaskov
Chairman & CEO, inHEART

Tom Gibbs
Senior Investment Director, Debiopharm Innovation Fund SA

Yves Nordmann
Co-Founder & CMO, docdok.health Ltd.

2024 Sponsor

BRONZE SPONSOR:
• Biosaxony